VALIANT FUND
NSAR-B, EX-27, 2000-10-30
Previous: VALIANT FUND, NSAR-B, EX-27, 2000-10-30
Next: ALEXION PHARMACEUTICALS INC, DEF 14A, 2000-10-30



<TABLE> <S> <C>

<ARTICLE> 6
<CIK> 0000899090
<NAME> THE VALIANT FUND
<SERIES>
   <NUMBER> 042
   <NAME> TAX-EXEMPT MONEY MARKET - CLASS D

<S>                             <C>
<PERIOD-TYPE>                   12-MOS
<FISCAL-YEAR-END>                          AUG-31-2000
<PERIOD-START>                             SEP-01-1999
<PERIOD-END>                               AUG-31-2000
<INVESTMENTS-AT-COST>                        206756071
<INVESTMENTS-AT-VALUE>                       206756071
<RECEIVABLES>                                  1033380
<ASSETS-OTHER>                                  159797
<OTHER-ITEMS-ASSETS>                                 0
<TOTAL-ASSETS>                               207949248
<PAYABLE-FOR-SECURITIES>                             0
<SENIOR-LONG-TERM-DEBT>                              0
<OTHER-ITEMS-LIABILITIES>                       691250
<TOTAL-LIABILITIES>                             691250
<SENIOR-EQUITY>                                      0
<PAID-IN-CAPITAL-COMMON>                     207421423
<SHARES-COMMON-STOCK>                            75379<F1>
<SHARES-COMMON-PRIOR>                                0<F1>
<ACCUMULATED-NII-CURRENT>                            0
<OVERDISTRIBUTION-NII>                               0
<ACCUMULATED-NET-GAINS>                              0
<OVERDISTRIBUTION-GAINS>                        163425
<ACCUM-APPREC-OR-DEPREC>                             0
<NET-ASSETS>                                 207257998
<DIVIDEND-INCOME>                                    0
<INTEREST-INCOME>                              7681464
<OTHER-INCOME>                                       0
<EXPENSES-NET>                                  408316
<NET-INVESTMENT-INCOME>                        7273148
<REALIZED-GAINS-CURRENT>                       (42330)
<APPREC-INCREASE-CURRENT>                            0
<NET-CHANGE-FROM-OPS>                          7230818
<EQUALIZATION>                                       0
<DISTRIBUTIONS-OF-INCOME>                          435<F1>
<DISTRIBUTIONS-OF-GAINS>                             0<F1>
<DISTRIBUTIONS-OTHER>                                0<F1>
<NUMBER-OF-SHARES-SOLD>                      581997281
<NUMBER-OF-SHARES-REDEEMED>                  663039639
<SHARES-REINVESTED>                                 34
<NET-CHANGE-IN-ASSETS>                        81084654
<ACCUMULATED-NII-PRIOR>                              0
<ACCUMULATED-GAINS-PRIOR>                            0
<OVERDISTRIB-NII-PRIOR>                              0
<OVERDIST-NET-GAINS-PRIOR>                      121095
<GROSS-ADVISORY-FEES>                           408253
<INTEREST-EXPENSE>                                   0
<GROSS-EXPENSE>                                 413409
<AVERAGE-NET-ASSETS>                             62300<F1>
<PER-SHARE-NAV-BEGIN>                             1.00<F1>
<PER-SHARE-NII>                                    .01<F1>
<PER-SHARE-GAIN-APPREC>                            .00<F1>
<PER-SHARE-DIVIDEND>                               .01<F1>
<PER-SHARE-DISTRIBUTIONS>                            0
<RETURNS-OF-CAPITAL>                                 0
<PER-SHARE-NAV-END>                               1.00<F1>
<EXPENSE-RATIO>                                    .70<F1>
<FN>
<F1>Class D
</FN>




</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission